retatrutide type 2 diabetes phase 2 results 2024 ada 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Pharmacological therapies for type 2
Description
That number still catches me off guard when I step on the scale
Kod semaglutida su opisani i veoma retki sluajevi ozbiljnog poremeaja vida (NAION), zbog ega je vano reagovati ako se javi nagla promena vida ili iznenadno pogoranje vida
The mechanism for why GLP-1 drug use may lead to wet AMD is not well established, but a predominant theory is that lowering blood sugar rapidly leads to a lack of oxygen in the retina
However, natural GLP-1 can easily be degraded by dipeptidyl peptidase 4 (DPP-4) in vivo and lose its activity
This understanding ensures accurate dosing and safe administration
To view a copy of this licence, visit About this article Cite this article Aydin, ., Meijnikman, A.S., de Jonge, P.A
